N. Thalassinos - Concepedia

Author

N. Thalassinos

Also Known As

H. Takama, N THALASSINOS, N Thalassinos, N. C. Thalassinos, N. THALASSINOS, N. Thalassinos, N.C. Thalassinos, NC Thalassinos

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Evangelismos Hospital National and Kapodistrian University of Athens Athens Euroclinic Athens State University Diabetes Australia

About

N. Thalassinos is an author at Evangelismos Hospital specializing in medicine, pathology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	388
2	Health Sciences	4	4	202
3	Endocrinology	3	3	210
4	Hepatology	1	1	34
5	Nephrology	1	1	33

N. Thalassinos

Publications

844

Citations

H-Index

Page 1

	Year	Citations
The Desmopressin and Combined CRH-Desmopressin Tests in the Differential Diagnosis of ACTH-Dependent Cushing’s Syndrome: Constraints Imposed by the Expression of V2 Vasopressin Receptors in Tumors with Ectopic ACTH Secretion Stylianos Tsagarakis, C. Tsigos, Vasilis Vasiliou, The Journal of Clinical Endocrinology & Metabolism Clinical DisordersAdrenal GlandPituitary GlandHuman GrowthRoc Curve Closest	2002	84
A Reappraisal of the Utility of Somatostatin Receptor Scintigraphy in Patients with Ectopic Adrenocorticotropin Cushing’s Syndrome Stylianos Tsagarakis, Marietta Christoforaki, H Giannopoulou, The Journal of Clinical Endocrinology & Metabolism Somatostatin Receptor ScintigraphyAdrenal GlandEndocrine OncologyBronchial CarcinoidsEctopic Acth Hypersecretion	2003	80
Elevated post‐dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo‐pituitary adrenal axis in patients with adrenal incidentalomas S Tsagarakis, C. Roboti, Panagiotis Kokkoris, Clinical Endocrinology	1998	77
The low‐dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome Stylianos Tsagarakis, Panagiotis Kokkoris, C. Roboti, Clinical Endocrinology	1998	64
Does subclinical hypercortisolism adversely affect the bone mineral density of patients with adrenal incidentalomas? D. Hadjidakis, Stylianos Tsagarakis, C. Roboti, Clinical Endocrinology	2003	58
The Application of the Combined Corticotropin-Releasing Hormone plus Desmopressin Stimulation during Petrosal Sinus Sampling Is Both Sensitive and Specific in Differentiating Patients with Cushing’s Disease from Patients with the Occult Ectopic Adrenocorticotropin Syndrome S. Tsagarakis, Dimitra A. Vassiliadi, Ioannis Kaskarelis, The Journal of Clinical Endocrinology & Metabolism	2007	57
FAILURE OF CORTICOSTEROID THERAPY TO CORRECT THE HYPERCALCÆMIA OF MALIGNANT DISEASE N. Thalassinos, G. F. Joplin The Lancet PathologyDermatologyAdrenal DiseaseMedicineEndocrine Disease	1970	48
Megavoltage pituitary irradiation lowers but seldom leads to safe GH levels in acromegaly: a long-term follow-up study N. Thalassinos, Stylianos Tsagarakis, G Ioannides, European Journal of Endocrinology Biochemical CureGh HypersecretionHuman GrowthGynecologyPharmacotherapy	1998	46
Interleukin‐6, a growth promoting cytokine, is present in human pituitary adenomas: an immunocytochemical study Stylianos Tsagarakis, George Kontogeorgos, P. Glannou, Clinical Endocrinology	1992	45
Food-Dependent Androgen and Cortisol Secretion by a Gastric Inhibitory Polypeptide-Receptor Expressive Adrenocortical Adenoma Leading to Hirsutism and Subclinical Cushing’s Syndrome:<i>In Vivo</i>and<i>in Vitro</i>Studies Stylianos Tsagarakis, C. Tsigos, V. Vassiliou, The Journal of Clinical Endocrinology & Metabolism	2001	42

Page 1